GenRx Voriconazole voriconazole 200mg tablet blister pack

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

voriconazole, Quantity: 200 mg

Tilgjengelig fra:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Voriconazole

Legemiddelform:

Tablet

Sammensetning:

Excipient Ingredients: magnesium stearate; polyvinyl alcohol; croscarmellose sodium; macrogol 8000; purified talc; titanium dioxide; lactose monohydrate

Administreringsrute:

Oral

Enheter i pakken:

56

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

Voriconazole is indicated for treatment of the following fungal infections: ? Invasive aspergillosis. ? Serious Candida infections (including C. krusei), including oesophageal and systemic Candida infections (hepatosplenic candidiasis, disseminated candidiasis, candidaemia). ? Serious fungal infections caused by Scedosporium spp and Fusarium spp. ? Other serious fungal infections, in patients intolerant of, or refractory to, other therapy.,Prophylaxis in patients who are at high risk of developing invasive fungal infections. The indication is based on studies including patients undergoing haematopoietic stem cell transplantation.

Produkt oppsummering:

Visual Identification: White coloured, modified oval-shaped, biconvex film-coated tablets, engraved with "APO" on one side and "VOR 200" on the other side.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Autorisasjon status:

Licence status A

Autorisasjon dato:

2016-01-27